Literature DB >> 29937915

Elimination half-lives of interleukin-6 and cytokine-induced neutrophil chemoattractant-1 synthesized in response to inflammatory stimulation in rats.

Takashi Kuribayashi1.   

Abstract

The elimination half-lives of in Interleukin-6 (IL-6) and cytokine-induced neutrophil chemoattractant-1 (CINC-1) in rats after inflammatory stimulation were investigated. Five male Sprague-Dawley rats were used (age, 9 weeks; body weight, 235-375 g). Turpentine oil was intramuscularly injected at a dose of 2 mL/kg body weight to induce acute inflammation. Blood was collected pre-injection and 6, 12, 24, 36, 48, 60, 72, 84, and 96 h after the turpentine oil injection. Serum concentrations of IL-6, CINC-1, and α2-macroglobulin (α2M) were measured by enzyme-linked immunosorbent assay. Half-lives were calculated as 0.693/elimination rate constant. The serum concentration of α2M peaked at 48 h after turpentine oil injection. Serum concentrations of IL-6 and CINC-1 increased and peaked at 12 and 24 h, respectively. The terminal elimination half-lives of IL-6 and CINC-1 were 15.5 and 29.9 h, respectively. The half-life of CINC-1 was significantly longer than that of IL-6 (P=0.006). These results suggested that these cytokines synthesized in response to inflammatory stimulation were rapidly eliminated in rats. The serum concentrations of these cytokines should be measured at an early stage if these cytokines will be used as surrogate inflammatory markers instead of acute-phase proteins.

Entities:  

Keywords:  CINC-1; Half-life; IL-6; rat; α2M

Year:  2018        PMID: 29937915      PMCID: PMC6010403          DOI: 10.5625/lar.2018.34.2.80

Source DB:  PubMed          Journal:  Lab Anim Res        ISSN: 1738-6055


α2-macroglobulin (α2M) is a typical acute phase protein and useful inflammatory marker in rats [12]. The serum concentrations of interleukins (IL)-6 and cytokine-induced neutrophil chemoattractant-1 (CINC-1) increased prior α2M increased, however, IL-1, IL-2, IL-4, IL-6, IL-10, and IFN-γ did not change in rats induced acute inflammation [3]. Moreover, serum concentrations of α2M increased in rats injected the mixture of IL-6 and CINC-1 rich fraction separated from serum obtained from rats during acute inflammation. Then, IL-6 and CINC-1 are considered to contribute the production of α2M in rats [4567]. α2M was produced by the liver and the serum concentrations of α2M decreased in impairment liver rats [8]. Then, α2M is not suitable inflammatory marker in the case of estimation of substance induced hepatic toxicity in non-clinical studies [8]. The serum concentrations of IL-6 and CINC-1 related with the change of α2M. Then, IL-6 and CINC-1 are considered the surrogate inflammatory markers instead of α2M. In general, cytokines are rapidly eliminated in vivo with extremely short biological half-lives [91011]. However, few reports are available on the elimination rates of IL-6 and CINC-1 produced in vivo during acute inflammation. Therefore, the aim of this study was to clarify the elimination half-lives of IL-6 and CINC-1 in rats in response to inflammatory stimulation and to determine the optimal timing for evaluating IL-6 and CINC-1 as surrogate inflammatory markers in rats. Five Sprague-Dawley rats (age, 9 weeks; body weight, 235–375 g) were purchased from CLEA Japan, Inc. (Tokyo, Japan). The present animal experiment was approved by the Institutional Animal Care and Use Committee of Azabu University (approval no. 160610-2). Turpentine oil (Wako Pure Chemical Industries, Co., Ltd., Osaka, Japan) was intramuscularly injected at a dose of 2 mL/kg body weight. Turpentine oil has been used to induce inflammation in many previous studies, reliably and with little individual variation, and was therefore chosen to induce inflammation in this study [12]. Blood was collected by ventricular puncture before turpentine oil injection and 6, 12, 24, 36, 48, 60, 72, 84, and 96 h after injection. Injection of turpentine oil and collection of blood were conducted under anesthesia with pentobarbital at dose of 3 mg/kg (Kyoritsu Seiyaku Corporation, Tokyo, Japan) to be reduced pain and stress. The serum concentrations of IL-6 and CINC-1 at pre-injection and 6, 12, 24, 36, 48, 60, 72, 84, and 96 h post-injection were measured using the commercial enzyme-linked immunosorbent assay (ELISA) kits (Thermo Fisher Scientific Inc., Waltham, MA, USA; Immuno-Biological Laboratories Co., Ltd., Gunma, Japan). All serum sample were diluted with standard diluent buffer of kits prior application in the ELISA. The standard curves ranged of 23.5 to 1500 pg/mL IL-6 and ranged of 4.69 to 300 pg/mL CINC-1 were obtained, respectively. The detection limit of IL-6 and CINC-1 were 23.5 and 4.69 pg/mL, respectively. The serum concentrations of α2M were measured by ELISA according to the procedure of Honjo et al. in samples collected pre-treatment and 24, 48, 72, and 96 h after the turpentine oil injection [4]. All samples were diluted with phosphate-buffered saline (ph7.2) prior application in the ELISA and measured by according to method of Honjo et al. The linear slope of serum IL-6 or CINC-1 concentration versus time was then plotted on log-linear regression. The elimination rate constant (K) was calculated using a minimum of three measured serum concentrations [13]. Half-life was calculated as follows: K (h−1)=(−2.303)×slope, Half-life (h)=0.693/K. The kinetic parameters of IL-6 and CINC-1 were analyzed using the paired Student's t-test. Differences in P values <0.05 were considered significant. The changes in serum concentrations of α2M, IL-6, and CINC-1 in rats are shown in Figures 1, 2, and 3, respectively. Kinetic parameters of IL-6 and CINC-1 are shown in Table 1. The serum concentrations of α2M increased and peaked at 48 h after turpentine oil injection, indicating that acute inflammation was successfully induced in the rats. The serum concentrations of IL-6 peaked at 12 h after the turpentine oil injection and were eliminated immediately. Serum concentrations of IL-6 were not detected after 72 h except in one rat (detection limit=23.5 pg/mL). Serum concentrations below the detection limit were set as zero. CINC-1 peaked at 24 h and exhibited biphasic elimination. The mean terminal half-lives of IL-6 and CINC-1 were 15.5 and 29.9 h, respectively. The half-life of CINC-1 was significantly longer than that of IL-6 (P=0.006).
Figure 1

Serum concentrations of α2-macroglobulin (α2M) in rats after injection of turpentine oil at dose of 2 mL/kg body weight. Each point represented as mean±standard deviation (n=5).

Figure 2

Serum concentrations of interleukin-6 (IL-6) in rats after injection of turpentine oil at dose of 2 mL/kg body weight (n=5). Each point represented as mean±standard deviation (n=5). IL-6 was not detected (ND) except for 1 rats at 72 hours after injection of turpentine oil and ND was calculated as zero. IL-6 was not detected at 84 and 96 hours after injection in all rats.

Figure 3

Serum concentrations of cytokine-induced neutrophil chemoattractant-1 (CINC-1) in rats after injection of turpentine oil at dose of 2 mL/kg body weight (n=5). Each point represented as mean±standard deviation (n=5).

Table 1

Kinetic parameters of interleukin-6 (IL-6) and cytokine-induced neutrophil chemoattractant-1 (CINC-1) in rats

CytokinesCmax (pg/mL)Cmax/pre-valueElimination rate constantElimination half-life (hr)
IL-6817.4±358.826.7±16.10.0463±0.009215.5±3.4
CINC-111490.1±3167.920.8±5.80.0238*±0.004429.9*±5.9

Values expressed as mean±standard deviation (n=5). Significant difference versus IL-6 is indicated: * (P<0.05).

Discussion

The terminal half-lives of IL-6 and CINC-1 were 15.5 and 29.9 h, respectively. The half-lives of IL-6 and CINC-1 were shorter than α2M and AAG, typical acute-phase proteins in rats [14], suggesting that IL-6 and CINC-1 in rats are rapidly eliminated after production by acute inflammatory stimulation. The half-lives of targeted and non-targeted mIFN-α2 in mice after intravenous dosing were reported to be 16.2 and 17.1 h, respectively [15]. These results are compatible with the half-lives of IL-6 and CINC-1 in this study. The half-life of PEG-IFN-α2 was 46.1 h in human after subcutaneous administration. The half-lives of PEG-IFN-β1a and IFN-β1a were 86.0 and 61.7 h, respectively [16]. IFN conjugated with polyethylene glycol slows down the decomposition of IFN [171819]. Moreover, these IFNs were subcutaneously administered in humans and slowly absorbed [20], suggesting that IFN slowly is absorbed and decomposes. Based on these results, the half-lives of IL-6 and CINC-1 estimated in this study were considered to be appropriate. The elimination half-life of AAG is significantly longer than that of α2M in rats [15]. Similarly, a significant difference in the elimination half-lives of CINC-1 and IL-6 was observed in rats. Additionally, the survival time of CINC-1 was significantly longer than that of IL-6 in rats. However, the serum concentrations of IL-6 beyond 72 h were below the detection limit of the commercial ELISA kit used in this study. Conversely, the serum concentrations of CINC-1 were detectable until 96 h (detection limit=4.69 pg/mL). Therefore, the possibility of a short half-life for IL-6 is not negligible. Further measurement of serum concentrations of IL-6 using high sensitivity ELISA kits is necessary to confirm any significant differences in IL-6 and CINC-1 half-lives. In conclusion, IL-6 and CINC-1 eliminated rapidly than α2M in rats. Then, if these cytokines will be used as surrogate inflammatory markers instead of α2M, the serum concentrations of these cytokines should be measured at an early stage after peak concentration, from 12 to 18 hours after inflammatory stimulation.
  17 in total

1.  The effects of interleukin-6 and cytokine-induced neutrophil chemoattractant-1 on α₂-macroglobulin production in rats.

Authors:  Toshio Honjo; Takashi Kuribayashi; Tetsurou Seita; Yui Mokonuma; Ayaka Yamaga; Shunsuke Yamazaki; Shizuo Yamamoto
Journal:  Exp Anim       Date:  2010

Review 2.  The cytokines: a review of interleukins.

Authors:  R L Weber; V J Iacono
Journal:  Periodontal Clin Investig       Date:  1997

3.  Elimination Half-Lives of Acute Phase Proteins in Rats and Beagle Dogs During Acute Inflammation.

Authors:  Takashi Kuribayashi; Tetsuro Seita; Eiichi Momotani; Shunsuke Yamazaki; Kohei Hagimori; Shizuo Yamamoto
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

4.  Comparison of α2-macroglobulin synthesis by juvenile vs. mature rats after identical inflammatory stimulation.

Authors:  Takashi Kuribayashi; Tetsuro Seita; Katsuhito Kawato; Shunsuke Yamazaki; Shizuo Yamamoto
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

5.  Variation of serum alpha2-macroglobulin concentration in healthy rats and rats inoculated with Staphylococcus aureus or subjected to surgery.

Authors:  T Jinbo; M Motoki; S Yamamoto
Journal:  Comp Med       Date:  2001-08       Impact factor: 0.982

6.  Serum alpha2-macroglobulin and cytokine measurements in an acute inflammation model in rats.

Authors:  T Jinbo; T Sakamoto; S Yamamoto
Journal:  Lab Anim       Date:  2002-04       Impact factor: 2.471

7.  Pharmacokinetics of ketamine and xylazine in young and old Sprague-Dawley rats.

Authors:  Daphnée Veilleux-Lemieux; Aude Castel; Denise Carrier; Francis Beaudry; Pascal Vachon
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

Review 8.  Pegylated interferons for the treatment of chronic hepatitis C: pharmacological and clinical differences between peginterferon-alpha-2a and peginterferon-alpha-2b.

Authors:  Graham R Foster
Journal:  Drugs       Date:  2010       Impact factor: 9.546

9.  Phase I study of pegylated interferon-alpha-2b as an adjuvant therapy in Japanese patients with malignant melanoma.

Authors:  Naoya Yamazaki; Hisashi Uhara; Hidefumi Wada; Kenji Matsuda; Keiko Yamamoto; Takashi Shimamoto; Yoshio Kiyohara
Journal:  J Dermatol       Date:  2016-10       Impact factor: 4.005

10.  COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta-1a and subcutaneous interferon beta-1a over 2 weeks in healthy subjects.

Authors:  Xiao Hu; Shulian Shang; Ivan Nestorov; Jawad Hasan; Ali Seddighzadeh; Katherine Dawson; Bjørn Sperling; Brian Werneburg
Journal:  Br J Clin Pharmacol       Date:  2016-05-29       Impact factor: 4.335

View more
  10 in total

1.  Data Driven Mathematical Model of Colon Cancer Progression.

Authors:  Arkadz Kirshtein; Shaya Akbarinejad; Wenrui Hao; Trang Le; Sumeyye Su; Rachel A Aronow; Leili Shahriyari
Journal:  J Clin Med       Date:  2020-12-05       Impact factor: 4.241

Review 2.  Medium Cut-Off Dialysis Membrane and Dietary Fiber Effects on Inflammation and Protein-Bound Uremic Toxins: A Systematic Review and Protocol for an Interventional Study.

Authors:  Tjaša Herič; Tjaša Vivoda; Špela Bogataj; Jernej Pajek
Journal:  Toxins (Basel)       Date:  2021-03-29       Impact factor: 4.546

3.  Atorvastatin-mediated rescue of cancer-related cognitive changes in combined anticancer therapies.

Authors:  Junho Lee; Jin Su Kim; Yangjin Kim
Journal:  PLoS Comput Biol       Date:  2021-10-20       Impact factor: 4.475

4.  Key early proinflammatory signaling molecules encapsulated within circulating exosomes following traumatic injury.

Authors:  Sarah A Walsh; Thomas A Davis
Journal:  J Inflamm (Lond)       Date:  2022-05-12       Impact factor: 6.283

5.  Multi-scale mechanistic modelling of the host defence in invasive aspergillosis reveals leucocyte activation and iron acquisition as drivers of infection outcome.

Authors:  Henrique Al Ribeiro; Luis Sordo Vieira; Yogesh Scindia; Bandita Adhikari; Matthew Wheeler; Adam Knapp; William Schroeder; Borna Mehrad; Reinhard Laubenbacher
Journal:  J R Soc Interface       Date:  2022-04-13       Impact factor: 4.118

6.  Recombinant Klotho Protein Ameliorates Myocardial Ischemia/Reperfusion Injury by Attenuating Sterile Inflammation.

Authors:  Jinwoo Myung; Jin-Ho Beom; Ju-Hee Kim; Ji-Sun Woo; Incheol Park; Sung-Phil Chung; Yong-Eun Chung; Je-Sung You
Journal:  Biomedicines       Date:  2022-04-13

7.  Lymphocyte Population Changes at Two Time Points during the Acute Period of COVID-19 Infection.

Authors:  Giulia Scalia; Maddalena Raia; Monica Gelzo; Sara Cacciapuoti; Annunziata De Rosa; Biagio Pinchera; Riccardo Scotto; Lorella Tripodi; Mauro Mormile; Gabriella Fabbrocini; Ivan Gentile; Roberto Parrella; Giuseppe Castaldo; Filippo Scialò
Journal:  J Clin Med       Date:  2022-07-25       Impact factor: 4.964

Review 8.  Alarming Cargo: The Role of Exosomes in Trauma-Induced Inflammation.

Authors:  Sarah A Walsh; Benjamin W Hoyt; Cassie J Rowe; Devaveena Dey; Thomas A Davis
Journal:  Biomolecules       Date:  2021-03-31

9.  Frequency of Atrial Arrhythmia in Hospitalized Patients With COVID-19.

Authors:  Hirad Yarmohammadi; John P Morrow; Jose Dizon; Angelo Biviano; Frederick Ehlert; Deepak Saluja; Marc Waase; Pierre Elias; Timothy J Poterucha; Jeremy Berman; Alexander Kushnir; Mark P Abrams; Geoffrey A Rubin; Stephanie Jou; Jessica Hennessey; Nir Uriel; Elaine Y Wan; Hasan Garan
Journal:  Am J Cardiol       Date:  2021-02-20       Impact factor: 2.778

Review 10.  Cytokines: From Clinical Significance to Quantification.

Authors:  Chao Liu; Dewei Chu; Kourosh Kalantar-Zadeh; Jacob George; Howard A Young; Guozhen Liu
Journal:  Adv Sci (Weinh)       Date:  2021-06-10       Impact factor: 16.806

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.